|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2024―Feb―27 |
Viral infections causing asthma exacerbations in the age of biologics and the COVID-19 pandemic |
Pedro A. Lamothe, Violeta Capric, F. Eun-Hyung Lee |
2 |
[GO] |
2023―May―09 |
Home monitoring of coronavirus disease 2019 patients in different phases of disease |
Kalle Majoor, Adriane D.M. Vorselaars |
3 |
[GO] |
2023―May―03 |
Current challenges and perspectives in lung cancer care during COVID-19 waves |
Domenica Francesca Mariniello, Luigi Aronne, Maria Vitale, Angela Schiattarella, Raffaella Pagliaro, Klara Komici |
4 |
[GO] |
2023―Mar―17 |
The association of preexisting severe asthma with COVID-19 outcomes |
Paul D. Terry, R. Eric Heidel, Rajiv Dhand |
5 |
[GO] |
2023―Mar―14 |
Drug treatment of COVID-19 infection |
Grace Lui, Giovanni Guaraldi |
6 |
[GO] |
2023―Mar―14 |
The prevalence of childhood asthma: interpreting falling rates in the context of shifting measurement and the COVID-19 pandemic |
Sean M. Frey, Regina K. Rowe, Jill S. Halterman |
7 |
[GO] |
2023―Mar―06 |
Mass gathering events and transmission of respiratory tract infections: updates pre and post COVID-19 lockdown |
David S.C. Hui, Alimuddin Zumla |
8 |
[GO] |
2023―Mar―03 |
Airborne transmission of respiratory viruses including severe acute respiratory syndrome coronavirus 2 |
Julian W. Tang, Linsey C. Marr, Raymond Tellier, Stephanie J. Dancer |
9 |
[GO] |
2023―Mar―01 |
Nonpharmaceutical interventions for managing SARS-CoV-2 |
Caitriona Murphy, Jessica Y. Wong, Benjamin J. Cowling |
10 |
[GO] |
2023―Feb―24 |
Effectiveness and safety of coronavirus disease 2019 vaccines |
Ting Shi, Chris Robertson, Aziz Sheikh |
11 |
[GO] |
2022―Aug―08 |
Interstitial lung disease following coronavirus disease 2019 |
Eirini Vasarmidi, Mada Ghanem, Bruno Crestani |
12 |
[GO] |
2022―May―12 |
Editorial: Coronavirus disease 2019 (COVID-19) - advances in epidemiology, diagnostics, treatments, host-directed therapies, pathogenesis, vaccines, and ongoing challenges |
Alimuddin Zumla, David S.C. Hui |
13 |
[GO] |
2022―Mar―10 |
Advances in the epidemiology, clinical features, diagnosis, clinical management and prevention of coronavirus disease 2019 |
David S.C. Hui, Alimuddin Zumla |
14 |
[GO] |
2022―Feb―01 |
COVID-19 and other respiratory tract infections at mass gathering religious and sporting events |
Jaffar A. Al-Tawfiq, Sherif A. El-Kafrawy, Brian McCloskey, Esam I. Azhar |
15 |
[GO] |
2021―Dec―21 |
COPD in the COVID-19 era, challenging concepts and developments in COPD, and occupational exposures and susceptibilities |
Manish Joshi, Basil Varkey |
16 |
[GO] |
2021―Oct―25 |
Chronic obstructive pulmonary disease and COVID-19 |
Dave Singh, Alexander G. Mathioudakis, Andrew Higham |
17 |
[GO] |
2021―Oct―17 |
Obstructive lung diseases burden and COVID-19 in developing countries |
Ashutosh N. Aggarwal, Kuruswamy Thurai Prasad, Valliappan Muthu |
18 |
[GO] |
2021―Aug―25 |
COVID-19 outcomes in people with cystic fibrosis |
Pierre-Régis Burgel, Christopher Goss |
19 |
[GO] |
2021―Aug―25 |
Sleep medicine and coronavirus disease 2019 |
Cara M. Gill, Laura M. Piggott, Brian D. Kent |
20 |
[GO] |
2021―Jul―15 |
COVID-19 infection in patients with sarcoidosis |
Vivienne Kahlmann, Michael Manansala, Catharina C. Moor, Shiva Shahrara, Marlies S. Wijsenbeek, Nadera Sweiss |
21 |
[GO] |
2021―May―31 |
Editorial: COVID pandemic and Lung cancer: challenges lead to opportunities |
David E. Ost, Sneh Chauhan, Lisa Ramdhanie, Alan Fein |
22 |
[GO] |
2021―Mar―29 |
Editorial: Coronavirus disease 2019 (COVID-19) - advances in epidemiology, diagnostics, treatments, host-directed therapies, pathogenesis, vaccines, and ongoing challenges |
Michael S. Niederman, Alimuddin Zumla |
23 |
[GO] |
2021―Mar―04 |
Lethal zoonotic coronavirus infections of humans - comparative phylogenetics, epidemiology, transmission, and clinical features of coronavirus disease 2019, The Middle East respiratory syndrome and severe acute respiratory syndrome |
David S. Hui, Alimuddin Zumla, Julian W. Tang |
24 |
[GO] |
2021―Mar―03 |
COVID-19 new diagnostics development |
Jim F. Huggett, Jacob Moran-Gilad, J. Eugene Lee |
25 |
[GO] |
2021―Mar―03 |
Management of immunosuppressants in the era of coronavirus disease-2019 |
Michael Manansala, Robert Baughman, Richard Novak, Marc Judson, Nadera Sweiss |
26 |
[GO] |
2021―Feb―27 |
Host-directed therapies for COVID-19 |
Markus Maeurer, Renata Ramalho, Fu-Sheng Wang, Alimuddin Zumla |
27 |
[GO] |
2021―Feb―27 |
COVID-19 - pathogenesis and immunological findings across the clinical manifestation spectrum |
Rita Carsetti, Isabella Quinti, Franco Locatelli |
28 |
[GO] |
2021―Feb―27 |
Coronavirus disease 2019 management |
Kevin C. Wilson |
29 |
[GO] |
2021―Feb―21 |
The role of computed tomography scan in the diagnosis of COVID-19 pneumonia |
Ariana Axiaq, Ahmad Almohtadi, Samuel A. Massias, Dorette Ngemoh, Amer Harky |
30 |
[GO] |
2021―Jan―20 |
Palliative care considerations and ethical issues in the care of Covid-19 patients |
Basil Varkey |
31 |
[GO] |
2021―Jan―13 |
COVID-19 |
Rajen N. Naidoo, Mohamed F. Jeebhay |
32 |
[GO] |
2021―Jan―05 |
Pulmonary pathology of COVID-19 |
Alain C. Borczuk |
33 |
[GO] |
2020―Dec―28 |
A trio of articles on Covid-19, followed by articles on vaping, hypersensitivity pneumonitis, and several on obstructive airway and pulmonary diseases |
Manish Joshi, Basil Varkey |
34 |
[GO] |
2020―Dec―17 |
ICU preparedness in pandemics |
Gavin Harris, Amesh Adalja |
35 |
[GO] |
2020―Oct―26 |
Dealing with asthma during the turbulent times of coronavirus disease-2019 |
Zuzana Diamant, Nicola A. Hanania |
36 |
[GO] |
2020―Oct―16 |
Asthma and severe acute respiratory syndrome coronavirus 2019 |
Sara M. Assaf, Svitlana P. Tarasevych, Zuzana Diamant, Nicola A. Hanania |
37 |
[GO] |
2020―Mar―05 |
The explosive epidemic outbreak of novel coronavirus disease 2019 (COVID-19) and the persistent threat of respiratory tract infectious diseases to global health security |
Alimuddin Zumla, Michael S. Niederman |